These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes. Bolger GT; Marcus KA; Daly JW; Skolnick P J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279 [TBL] [Abstract][Full Text] [Related]
3. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain. Bolger GT; Skolnick P Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494 [TBL] [Abstract][Full Text] [Related]
4. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength. Bellemann P; Ferry D; Lübbecke F; Glossmann H Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of [3H]nitrendipine binding to brain and cardiac membranes by bacitracin. Smith JD; Bolger GT Can J Physiol Pharmacol; 1989 Dec; 67(12):1591-5. PubMed ID: 2560678 [TBL] [Abstract][Full Text] [Related]
6. Ion dependence of the partially purified mitochondrial dihydropyridine Ca2+ antagonist receptor. Zernig G; Reider N Mol Pharmacol; 1992 Jan; 41(1):45-52. PubMed ID: 1310145 [TBL] [Abstract][Full Text] [Related]
7. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla. Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272 [TBL] [Abstract][Full Text] [Related]
8. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma. Haase H; Wallukat G; Vetter R; Will H Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862 [TBL] [Abstract][Full Text] [Related]
9. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines. Reynolds IJ; Snowman AM; Snyder SH J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067 [TBL] [Abstract][Full Text] [Related]
10. Regulation of dihydropyridine calcium antagonist binding sites in the rat hippocampus following neurochemical lesions. Bolger GT; Basile AS; Janowsky AJ; Paul SM; Skolnick P J Neurosci Res; 1987; 17(3):285-90. PubMed ID: 3037095 [TBL] [Abstract][Full Text] [Related]
11. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes. Boles RG; Yamamura HI; Schoemaker H; Roeske WR J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride. Ishii A Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603 [TBL] [Abstract][Full Text] [Related]
13. Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites. Ishii A; Nishida K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1681-3. PubMed ID: 3219140 [TBL] [Abstract][Full Text] [Related]
14. Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites. Pauwels PJ; Van Assouw HP; Leysen JE Mol Pharmacol; 1987 Dec; 32(6):785-91. PubMed ID: 2826992 [TBL] [Abstract][Full Text] [Related]
15. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding. Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181 [TBL] [Abstract][Full Text] [Related]
16. Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents. Hogaboom GK; Mong S; Stadel JM; Crooke ST Mol Pharmacol; 1985 Feb; 27(2):236-45. PubMed ID: 2982090 [TBL] [Abstract][Full Text] [Related]
17. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Bellemann P; Ferry D; Lübbecke F; Glossman H Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299 [TBL] [Abstract][Full Text] [Related]
18. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel. Triggle DJ; Janis RA J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383 [TBL] [Abstract][Full Text] [Related]
19. Endogenous modulators of binding of [3H]nitrendipine in extracts of rat brain. Ebersole BJ; Gajary ZL; Molinoff PB J Pharmacol Exp Ther; 1988 Mar; 244(3):971-6. PubMed ID: 3252044 [TBL] [Abstract][Full Text] [Related]
20. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium. Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]